从血小板探讨血瘀证与肿瘤化疗耐药的关系及活血法作用机制
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金项目(81673797,82104961);北京市自然科学基金项目(7182142);中国中医科学院科技创新工程项目(CI2021A01814)


Exploration of the Relationship Between Blood Stasis Syndrome and Tumor Chemotherapy Resistance and the Mechanism of Activating Blood Circulation Based on Platelets
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    化疗是中晚期恶性肿瘤重要的治疗手段,其治疗效果与肿瘤微环境相互影响,其中血小板在微环境中与各种细胞之间复杂的相互作用是导致耐药形成的关键因素之一。化疗后患者血瘀证加重,而虚、寒、毒致瘀可能是导致化疗耐药的机制。现以血小板为切入点,初步探讨血瘀证与肿瘤化疗耐药的关系,阐述活血法降低耐药的发生机制,为活血类中药防治肿瘤转移提供理论依据,并为未来研究方向提供新思路。

    Abstract:

    Chemotherapy is an important treatment for mediate and advanced malignant tumors,and its therapeutic effect interacts with the tumor microenvironment,in which the complex interaction between platelets and various cells is one of the key factors leading to the formation of drug resistance.After chemotherapy,blood stasis syndrome worsened,and stasis caused by deficiency,cold and poison may be the mechanism leading to chemotherapy resistance.In this paper,the platelet was taken as the entry point to preliminarily explore the relationship between blood stasis syndrome and chemotherapy resistance of tumors,and analyze the mechanism of reducing drug resistance by activating blood circulation method,thus providing theoretical basis for the prevention and treatment of tumor metastasis by blood-activating traditional Chinese medicine and new ideas for future research.

    参考文献
    相似文献
    引证文献
引用本文

何杰,刘槟,王菁,花宝金,张培彤.从血小板探讨血瘀证与肿瘤化疗耐药的关系及活血法作用机制[J].世界中医药,2023,(03).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-11-04
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-04-11
  • 出版日期:
文章二维码